Breethe is a medical device company that develops a compact artificial lung for patients with acute and chronic lung problems. Breethe's system, called the OXY-1 System, is designed to remove carbon dioxide and add oxygen to a patient's blood, much like a working human lung would. The tech eliminates the need for bulky oxygen tanks andallows patients in need of ECMO therapy to move around more easily. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Health Care

Biotechnology

Breethe, Inc.

Dr. Bartley Griffith

Andrew J. Greenfield

Will Danzinger

Todd Tetreault

Thorsten Siess

The Leadership Team at Breethe, Inc. is responsible for driving the strategic vision and operational excellence of the company. This diverse group oversees key functions such as innovation, engineering, finance, and human resources, ensuring that the development and deployment of the OXY-1 System align with industry standards and patient needs. By leveraging their expertise, the team guides Breethe’s initiatives for growth and technological advancement in the medical device sector.

Leadership Team

Engineering Team

Healthcare Management Team

Leadership Team

About

Team members

Other teams at Breethe, Inc.

Engineering Team

Healthcare Management Team